Anika Therapeutics | Attività





Attività Cambiamento Data
Abbott USD 84.18B 182M 2025-09
Agenus USD 233.89M 48.67M 2025-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
Enanta Pharmaceuticals USD 280.73M 20.3M 2025-09
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Heron Therapeutics USD 248.95M 16.86M 2025-09
Insmed USD 2.36B 119.12M 2025-09
Integra LifeSciences USD 3.65B 21.45M 2025-09
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 192.82B 573M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Ligand Pharmaceuticals USD 1.48B 528.17M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
Merit Medical Systems USD 2.63B 44.95M 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 126.81B 2.99B 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 47.84B 787M 2025-12
Surmodics USD 178.56M 1.15M 2024-09
Veracyte USD 1.37B 23.68M 2025-09
Xencor USD 868.81M 10.61M 2025-09
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12


Anika Therapeutics Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.